Department of Animal Production and Preventive Veterinary Medicine, School of Veterinary Medicine and Animal Science, Sao Paulo State University (UNESP), Botucatu, Brazil; Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Santiago, Chile.
Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Santiago, Chile; Departamento de Ecología y Biodiversidad, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile; Centro de Investigación para la Sustentabilidad, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
Prev Vet Med. 2021 May;190:105316. doi: 10.1016/j.prevetmed.2021.105316. Epub 2021 Mar 2.
Faecal carriage of extended-spectrum cephalosporin-resistant Escherichia coli (ESC-R E. coli) in dogs has been reported worldwide and can reduce the effectiveness of treatments against bacterial infections. However, the drivers that influence faecal carriage of ESC-R E. coli in dogs are poorly understood. The aims of this study were to estimate the prevalence of ESC-R E. coli among dogs prior to their admission to a veterinary teaching hospital and to identify risk factors associated with the faecal carriage of ESC-R E. coli. Rectal swabs (n = 130) were collected from dogs and screened for ESC-R E. coli using MacConkey agar supplemented with cefotaxime (2 μg/mL). E. coli species was confirmed by MALDI-TOF and screening of extended-spectrum beta-lactamase (ESBL) genes was conducted by multiplex PCR. Questionnaires were completed by each dog's owner to test several human and dog characteristics associated with ESC-R E. coli. The prevalence of faecal carriage of ESC-R E. coli was 9.2 % and 67 % of ESC-R E. coli isolates harboured ESBL genes including CTX-M alone or in combination with TEM. All ESC-R E. coli isolates were resistant to ceftriaxone, cefpodoxime, and cefotaxime and were susceptible to cefoxitin and carbapenems. The likelihood of carrying ESC-R E. coli was 15 times higher (OR = 14.41 [95 % CI: 1.80-38.02], p < 0.01) if the dog was treated with antibiotics 3-12 months prior to sampling and 8 times higher (OR = 7.96 [95 % CI: 2.96-92.07], p < 0.01) if the dog had direct contact with livestock, but 15 times lower (OR = 0.07 [95 % CI: 0.01-0.32], p < 0.01) if the dog was dewormed during the previous year. Our findings confirm the faecal carriage of ESC-R E. coli in subclinical dogs and call for further investigation regarding the impact of deworming on antibiotic-resistant bacteria in companion animals.
在全球范围内,已报道狗携带具有广谱头孢菌素耐药性的大肠杆菌(ESC-R 大肠杆菌),这可能会降低针对细菌感染的治疗效果。然而,导致狗携带 ESC-R 大肠杆菌的因素尚不清楚。本研究的目的是在兽医教学医院入院前估计狗携带 ESC-R 大肠杆菌的流行率,并确定与 ESC-R 大肠杆菌粪便携带相关的危险因素。从狗的直肠拭子(n = 130)中采集样本,并使用添加头孢噻肟(2μg/ml)的麦康凯琼脂筛选 ESC-R 大肠杆菌。通过 MALDI-TOF 确认大肠杆菌种属,并通过多重 PCR 筛选扩展谱β-内酰胺酶(ESBL)基因。每个狗的主人都填写了一份问卷,以测试与 ESC-R 大肠杆菌相关的几个人与狗的特征。携带 ESC-R 大肠杆菌的粪便流行率为 9.2%,67%的 ESC-R 大肠杆菌分离株携带 ESBL 基因,包括 CTX-M 单独或与 TEM 联合携带。所有 ESC-R 大肠杆菌分离株对头孢曲松、头孢泊肟和头孢噻肟耐药,对头孢西丁和碳青霉烯类敏感。如果狗在采样前 3-12 个月接受抗生素治疗,则携带 ESC-R 大肠杆菌的可能性增加 15 倍(OR = 14.41 [95%CI:1.80-38.02],p < 0.01),如果狗与家畜直接接触,则携带 ESC-R 大肠杆菌的可能性增加 8 倍(OR = 7.96 [95%CI:2.96-92.07],p < 0.01),如果狗在前一年进行了驱虫,则携带 ESC-R 大肠杆菌的可能性降低 15 倍(OR = 0.07 [95%CI:0.01-0.32],p < 0.01)。我们的研究结果证实了 ESC-R 大肠杆菌在亚临床犬中的粪便携带,并呼吁进一步研究驱虫对伴侣动物中抗生素耐药菌的影响。